Chief Financial Officer
Johnny Stilou joined Nuevolution in February 2018. He has extensive experience in biotech and medtech. His most recent position was as CFO with Fritz Schur Technical Group. From 2008 – 2016 He was CFO at Veloxis Pharmaceuticals which is a listed mid cap company on Nasdaq in Copenhagen. Johnny has extensive experience with investor relations but also in financing and M&A. Originally, he is an auditor from KPMG.
Johnny has an MSc in Business Economics & Auditing from Copenhagen Business School, and an Executive Management Program from INSEAD.
Number of shares: 0
Number of warrants: 0